RPB/LCIF Low Vision Research Award

基金名称
RPB/LCIF Low Vision Research Award
资助机构
Research to Prevent Blindness (RPB)
地区
United States
研究领域
Eye Diseases
Ophthalmology
截止日期
December 15, 2021 (已过期)
基金规模
Upper $300,000USD Lower $150,000USD Awardees will be required to expend the award within three (3) years if granted the full $300,000. Otherwise, the awardee is required to expend the initial $150,000 award payment within two (2) years.
联系方式
Pattie Moran, Director of Grants Administration pmoran@rpbusa.org
申请资格
Full-time department Chairs from any institution of higher education in the U.S. can nominate only one candidate per department. Candidates must hold a primary academic position as Assistant Professor through full Professor. We particularly encourage applications from relevant departments/disciplines such as Neuroscience, Psychology, Engineering, Computer Science, Optometry, and others. Interim or acting Chairs cannot nominate a candidate for this award. Ophthalmology Chairs are not eligible for this award
说明
The RPB / LCIF Award is intended to provide seed funding for high-risk/high-gain, innovative, cutting-edge research which demonstrates out-of-the-box thinking. We strongly encourage interdisciplinary collaboration within the scope of the proposed research. The RPB / LCIF Award will NOT fund evaluations of existing interventions and educational programs; epidemiological or demographic studies; or Phase III trials. Intervention development, proof of concept studies, and feasibility studies are eligible. Phase II trials are eligible if the applicant clearly demonstrates that the LVRA budget covers the cost of the Phase II trial; or if not, the applicant needs to explain how he/she proposes to secure additional funding.The proposed research cannot be funded - previously or currently - by NEI, NIH, or other federal funders, although modest initial funding by private funders/foundations is acceptable. The purpose of the award is to serve as a catalyst to specific lines/kinds of research not currently happening. Eligibility Full-time department Chairs from any institution of higher education in the U.S. can nominate only one candidate per department. Candidates must hold a primary academic position as Assistant Professor through full Professor. We particularly encourage applications from relevant departments/disciplines such as Neuroscience, Psychology, Engineering, Computer Science, Optometry, and others. Interim or acting Chairs cannot nominate a candidate for this award. Ophthalmology Chairs are not eligible for this award

基金资源

Purdue Grant Writing Lab: Introduction to Grant Writing 打开链接
University of Wisconsin Writing Center: Planning and Writing a Grant Proposal 打开链接

快速分享


将截止日期添加到日历

December 15, 2021

你有想要在此列出的基金申报机会吗?

立即提交你的基金合作意向,发送至 support@peeref.com,我们会尽快为你审核。


Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

相关基金

International Bioethics Research Training Program (D43 Clinical Trial Optional)
Health Jun 06, 2024 12:00:00 AM EDT $230,000
Aged Care Services - Specialist Dementia Care Program
Aged Care 30-Jun-2024 $5,500,000.00
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science for UM1 CTSA Hub Awards (RC2 Clinical Trials Not Allowed)
Health Sep 13, 2024 12:00:00 AM EDT $500,000
Leading Engineering for America's Prosperity, Health, and Infrastructure
Science and Technology and other Researc... Sep 16, 2024 12:00:00 AM EDT $2,000,000
Industrialization and Translation of Extracellular Vesicles for use in Regenerative Medicine (U43/U44 Clinical Trials Not Allowed)
Health Jun 06, 2025 12:00:00 AM EDT $295,924
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)
Health Sep 05, 2025 12:00:00 AM EDT $300,000
Advancing Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional)
Health Sep 05, 2025 12:00:00 AM EDT $1,838,436
MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health Services to Scale)
Medicine September 30, 2025 Up to 200,000,000 USD
MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health Services to Scale)
Medicine September 30, 2025 Up to 25,000,000 USD
MOMENTUM (Moving integrated, quality Maternal, Newborn, and Child Health and Family Planning and Reproductive Health services to scale): MOMENTUM Monitoring and evaluation, knowledge management and translation
Medicine September 30, 2025 Up to 25,000,000 USD